Royalty Pharma (RPRX) Net Income Attributable to Noncontrolling Interests (2019 - 2026)
Royalty Pharma (RPRX) recorded Income from Non-Controlling Interests of $63.6 million in Q2 2026, up 5.2% from $60.46 million a year earlier but down 63.4% from the prior quarter.
Powered by 
Analysis
Royalty Pharma (RPRX) Net Income Attributable to Noncontrolling Interests (2019 - 2026) Analysis & Trends
On a TTM basis, Royalty Pharma's Income from Non-Controlling Interests came in at $534.87 million as of Jun 30, 2026, down 17.0% year-over-year; for FY2025, it was $553.25 million, up 17.3% from FY2024.
- Annual Income from Non-Controlling Interests has a five-year compound annual growth rate of -5.3% (FY2020 to FY2025).
- Across earlier years, Income from Non-Controlling Interests came in at $471.83 million in FY2024 (-16.5%), $565.25 million in FY2023 (+201.9%), $187.23 million in FY2022 (-69.9%) and $621.47 million in FY2021 (-14.5%).
- Quarterly Income from Non-Controlling Interests has ranged from -$153.95 million in Q4 2022 to $262.37 million in Q3 2024 over the past five years.
- On a year-over-year basis, Income from Non-Controlling Interests rose in three of the last seven quarters, with growth averaging 44.7%.
- Peak year-over-year performance for Income from Non-Controlling Interests in the last five years was growth of 425.1% in Q3 2024, against a decline of 76.6% in Q4 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $173.57 million (Q1 2026), $141.71 million (Q4 2025) and $155.99 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCI Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Rocket Companies | 41.00 Bn | 29.82 Bn | - | - |
| 2 | Royalty Pharma | 39.88 Bn | 40.21 Bn | - | 121.96 Mn |
| 3 | Orix | 36.75 Bn | 7.39 Bn | 13.83 Bn | 4.84 Mn |
| 4 | Federal National Mortgage Association Fannie Mae | 25.40 Bn | -16,108.71 Bn | - | - |
| 5 | Royal Gold | 23.20 Bn | 22.41 Bn | 402.46 Mn | 676,000.00 |
| 6 | Affirm Holdings | 22.35 Bn | 15.40 Bn | - | - |
| 7 | Synchrony Financial | 22.29 Bn | -45.34 Bn | - | - |
| 8 | Annaly Capital Management | 14.69 Bn | 5.72 Bn | - | 1.06 Mn |
| 9 | Ares Capital | 14.04 Bn | 11.79 Bn | - | - |
| 10 | Federal Home Loan Mortgage | 12.55 Bn | -328.43 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 121.96 Mn |
| Jun 30, 2026 | 63.60 Mn |
| Mar 31, 2026 | 173.57 Mn |
| Dec 31, 2025 | 141.71 Mn |
| Sep 30, 2025 | 155.99 Mn |
| Jun 30, 2025 | 60.46 Mn |
| Mar 31, 2025 | 195.08 Mn |
| Dec 31, 2024 | 126.14 Mn |
| Sep 30, 2024 | 262.37 Mn |
| Jun 30, 2024 | 92.37 Mn |
| Mar 31, 2024 | -9.05 Mn |
| Dec 31, 2023 | 223.25 Mn |
| Sep 30, 2023 | 49.96 Mn |
| Jun 30, 2023 | 123.71 Mn |
| Mar 31, 2023 | 168.33 Mn |
| Dec 31, 2022 | -153.95 Mn |
| Sep 30, 2022 | 77.76 Mn |
| Jun 30, 2022 | 187.09 Mn |
| Mar 31, 2022 | 76.32 Mn |
| Dec 31, 2021 | 45.77 Mn |
API Access
Royalty Pharma Net Income Attributable to Noncontrolling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=RPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "RPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=RPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();